David Myl

David Myl has extensive experience in clinical operations and trial management, currently serving as the Director of Clinical Operations at Progenics Pharmaceuticals, Inc. since 2019. Prior to this role, David held the position of Head of Monitoring Oversight at Regeneron Pharmaceuticals, Inc. from 2011 to 2019. David also served as Managing Director at Mylstone Trial Management, LLC from 2005 to 2011. Earlier in David's career, a significant tenure at Roche from 1975 to 2004 as Global Head/Director contributed to a robust foundation in the pharmaceutical industry.